參考文獻 |
1. A. Patapoutian, S. Tate, C.J. Woolf. Transient receptor potential channels: targeting pain at the source. Nat. Rev. Drug Discov., 8 (2009), pp. 55–68.
2. A.M. Patwardhan, P.E. Scotland, A.N. Akopian, K.M. Hargreaves. Activation of TRPV1 in the spinal cord by oxidized linoleic acid metabolites contributes to inflammatory hyperalgesia. Proc. Natl. Acad. Sci. USA, 106 (2009), pp. 18820–18824.
3. Bennett GJ, Xie YK. (1988). A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain. 33:87–107.
4. Baron, R., Binder, A. and Wasner, G. (2010). Neuropathic pain: diagnosis, pathophysiological mechanisms, and treatment. Lancet Neurol 9(8): 807-19.
5. Clatworthy AL, Illich PA, Castro GA, Walters ET. (1995). Role of peri-axonal inflammation in the development of thermal hyperalgesia and guarding behavior in a rat model of neuropathic pain. Neurosci Lett 184: 5–8.
6. Choi JW., Lee SY., Choi Y. (1996). Identification of a putative G-protein-coupled receptor induced during activation-induced apoptosis of T cells. Cell Immunol. Fed 25;168(1):78-84.
7. Caterina MJ, Schumacher MA, Tominaga M, Rosen TA, Levine JD, Julius D. (1997). The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature;389:816–824.
8. Campbell, J. N. and Meyer, R. A. (2006). Mechanisms of neuropathic pain. Neuron 52(1): 77-92.
9. Canessa CM. Structural biology: Unexpected opening. Natrue. (2007);449(7160):293-294.
10. Costigan M, Scholz J, Woolf CJ. (2009). Neuropathic pain: a maladaptive response of the nervous system to damage. Annu Rev Neurosci 32:1–32.
11. Chan, Y. J., C. W. Huang, C. S. Lin, W. H. Chang and W. H. Sun. Expression and Function of Proton-Sensing G-Protein-Coupled Receptors in Inflammatory Pain. Mol Pain 5, (2009): 39.
12. Clark A. K., Old E. A., Malcangio M. (2013). Neuropathic pain and cytokines: current perspectives.J. Pain Res. 6, 803–814 10.
13. David, S., & Aguayo, A. J. (1981). Axonal elongation into PNS "bridges" after CNS injury in adult rats. Science, 214, 931-933.
14. Dworkin RH, O’Connor AB, Backonja M, Farrar JT, Finnerup NB, Jensen TS, Kalso EA, Loeser JD, Miaskowski C, Nurmikko TJ, Portenoy RK, Rice AS, Stacey BR, Treede RD, Turk DC, Wallace MS. (2007). Pharmacologic management of neuropathic pain: evidence-based recommendations. Pain.132:237–251.
15. Dubovy P. Wallerian degeneration and peripheral nerve conditions for both axonal regeneration and neuropathic pain induction. Ann Anat. 2011;194(4):267–75.
16. Gaudet AD, Popovich PG, Ramer MS. (2011). Wallerian degeneration: Gaining perspective on inflammatory events after peripheral nerve injury, Journal of Neuroinflammation. 8: 110.
17. Hargreaves K, Dubner R, Brown F, Flores C, Joris J. (1988). A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain.32:77–88.
18. Huang CW, Tzeng JN, Chen YJ, Tsai WF, Chen CC, Sun WH. (2007). Nociceptors of dorsal root ganglion express proton-sensing G-protein-coupled receptors. Mol Cell Neurosci. Oct; 36(2):195-120.
19. Ishii S, Kihara Y, Shimizu T. (2005). Identification of T cell death-associated gene 8 (TDAG8) as a novel acid sensing G-protein-coupled receptor. J Biol Chem. Mar 11;280(10):9083-7.
20. Ihara, Y., Y. Kihara, F. Hamano, K. Yanagida, Y. Morishita, A.Kunita, T. Yamori, M. Fukayama, H. Aburatani, T. Shimizu and S. Ishii. The G Protein-Coupled Receptor T-Cell Death-Associated Gene 8 (TDAG8) Facilitates Tumor Development by Serving as an Extracellular Ph Seneor. Proc Natl Acad Sci U S A 107, no. 40 (2010): 17309-14.
21. Jensen, T. S., Gottrup, H., Sindrup, S. H. and Bach, F. W. (2001). The clinical picture of neuropathic pain. Eur J Pharmacol 429(1-3): 1-11.
22. Kim SH, Chung J-M. (1992). An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat. Pain 50:355–363.
23. M. A. Thacker, Clark, A. K., Marchand, F., and McMahon, S. B. (2007). Pathophysiology of peripheral neuropathic pain: immune cells and molecules. Anesth Analg 105, 838-847
24. Mazzuca M, Heurteaux C, Alloui A, Diochot S, Baron A, Voilley N, Blondeau N, Escoubas P, Gélot A, Cupo A, Zimmer A, et al. A tarantula peptide against pain via ASIC1a channels and opioid mechanisms. Nat Neurosci. 2007;10(8):943–945.
25. Moalem, G; Tracey, DJ; (2006) Immune and inflammatory mechanisms in neuropathic pain. Brain Research Reviews , 51 (2) pp. 240-264.
26. Ohtori S, Inoue G, Koshi T, Ito T, Doya H, Saito T, Moriya H, Takahashi K. Up-regulation of acid-sensing ion channel 3 in dorsal root ganglion neurons following application of nucleus pulposus on nerve root in rats. Spine. 2006;31(18):2048–2052.
27. Reeh, P. W., and Stenn, K. H. (1996). Tissue acidosis in nociception and pain. Brain Research, 113, 143-151.
28. Radu CG, Yang LV, Riedinger M, Au M, Witte ON (2004). T cell chemotaxis to lysophosphatidylcholine through the G2A receptor. Proc Natl Acad Sci U S A. Jan 6;101(1):245-50.
29. Seltzer, Z., Dubner, R. and Shir, Y. (1990). A novel behavioral model of neuropathic pain disorders produced in rats by partial sciatic nerve injury. Pain , 43, 205-218.
30. Scholz J, and Woolf CJ. (2002). Can we conquer pain? Net Neurosci. Nov;5 Suppl:1062-7
31. Stockand JD, Staruschenko A, Pochynyuk O, Booth RE, Silverthorn DU. (2008). Insight toward epithelial Na+ channel mechanism revealed by the acid-sensing ion channel 1 structure. IUBMB Life. 60(9):620–628.
32. Tosa N1, Murakami M, Jia WY, Yokoyama M, Masunaga T, Iwabuchi C, Inobe M, Iwabuchi K, Miyazaki T, Onoe K, Iwata M, Uede T. (2003). Critical function of T cell death-associated gene 8 in glucocorticoid-induced thymocyte apoptosis. Int Immunol. 2003 Jun;15(6):741-9
33. von Frey M (1896). Untersuchunger über die Sinnesfunctionen der menschlichen Haut. Bandes der Abhandlungen der mathematisch-physischen Classe der Königl. Sächsischen Gesellschaft der Wissenschaften, 23: 175-266.
34. van Zwieten R, Wever R, Hamers MN, Roos D. (1981). Extracellular proton release by stimulated neutrophils. J Clin Invest 68:310-313.
35. Voilley N, de Weille J, Mamet J, Lazdunski M. (2001). Nonsteroid anti-inflammatory drugs inhibit both the activity and the inflammation-induced expression of acid-sensing ion channels in nociceptors. J Neurosci. 21(20):8026–8033.
36. van der Wal Selina, Cornelissen Lisa, Behet Marije, Vaneker Michiel, Steegers Monique, Vissers Kris. (2015) Behavior of neuropathic pain in mice following chronic constriction injury comparing silk and catgut ligatures. SpringerPlus 4: 225. doi:10.1186/s40064-015-1009-4.
37. Woolf CJ and Mannion RJ. (1999). Pain: neuropathic pain: aetiology, symptoms, mechanisms and managment. Lancet 353: 1959–64
38. Walker KM, Urban L, Medhurst SJ, Patel S, Panesar M, Fox AJ, McIntyre P (2003) The VR1 Antagonist Capsazepine Reverses Mechanical Hyperalgesia in Models of Inflammatory and Neuropathic Pain. J Pharmacol Exp Ther 304: 56-62
39. Wang JQ, Kon J, Mogi C, Tobo M, Damirin A, Sato K, Komachi M, Malchinkhuu E, Murata N, Kimura T, Kuwabara A, Wakamatsu N, Koizumi H, Uede T, Tsujimoto G, Kurose H, Sato T, Harada A, Misawa N, Tomura H, Okajima F. (2004). TDAG8 is a proton-sensing and psychosine-senstive G-protein-coupled receptor. J Biol Chem. Oct 29;279(44):45626-33.
40. Wemmie JA, Price MP, Welsh MJ. (2006). Acid-sensing ion channels: Advances, questions and therapeutic opportunities. Trends Neurosci. 29(10): 578–586.
41. Xu B, Descalzi G, Ye HR, Zhuo M, Wang YW. (2012). Translational investigation and treatment of neuropathic pain. Mol Pain. 8:15.
42. Zhao X, Wang C, Cui WG, MA Q, Zhou WH. (2015) Fisetin exerts antihyperalgesic effect in a mouse model of neuropathic pain: engagemen of spinal serotonergic system. Sci Rep. 2015 Mar 12;5:9043. doi: 10.1038/srep09043. |